JPS6251616A - 糖質輸液剤 - Google Patents

糖質輸液剤

Info

Publication number
JPS6251616A
JPS6251616A JP18850785A JP18850785A JPS6251616A JP S6251616 A JPS6251616 A JP S6251616A JP 18850785 A JP18850785 A JP 18850785A JP 18850785 A JP18850785 A JP 18850785A JP S6251616 A JPS6251616 A JP S6251616A
Authority
JP
Japan
Prior art keywords
palatinose
fructose
glucose
infusion
carbohydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP18850785A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6354691B2 (enExample
Inventor
Kamejiro Yamashita
山下　亀次郎
Koichi Kawai
川井　紘一
Kazumasa Suzuki
一正 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MITSUI SEITO KK
Terumo Corp
Mitsui DM Sugar Co Ltd
Original Assignee
MITSUI SEITO KK
Terumo Corp
Mitsui Sugar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MITSUI SEITO KK, Terumo Corp, Mitsui Sugar Co Ltd filed Critical MITSUI SEITO KK
Priority to JP18850785A priority Critical patent/JPS6251616A/ja
Publication of JPS6251616A publication Critical patent/JPS6251616A/ja
Publication of JPS6354691B2 publication Critical patent/JPS6354691B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP18850785A 1985-08-29 1985-08-29 糖質輸液剤 Granted JPS6251616A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP18850785A JPS6251616A (ja) 1985-08-29 1985-08-29 糖質輸液剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18850785A JPS6251616A (ja) 1985-08-29 1985-08-29 糖質輸液剤

Publications (2)

Publication Number Publication Date
JPS6251616A true JPS6251616A (ja) 1987-03-06
JPS6354691B2 JPS6354691B2 (enExample) 1988-10-28

Family

ID=16224929

Family Applications (1)

Application Number Title Priority Date Filing Date
JP18850785A Granted JPS6251616A (ja) 1985-08-29 1985-08-29 糖質輸液剤

Country Status (1)

Country Link
JP (1) JPS6251616A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004045312A1 (ja) * 2002-11-18 2004-06-03 Shin Mitsui Sugar Co., Ltd. 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0441819U (enExample) * 1990-08-08 1992-04-09

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004045312A1 (ja) * 2002-11-18 2004-06-03 Shin Mitsui Sugar Co., Ltd. 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料
KR101018610B1 (ko) * 2002-11-18 2011-03-02 미츠이 세이토 가부시키가이샤 혈당치 상승 억제제 및 체지방 축적 억제제, 그리고식용재료
US9017745B2 (en) 2002-11-18 2015-04-28 Mitsui Sugar Co., Ltd. Method of using isomaltulose to suppress body fat accumulation
US9017744B2 (en) 2002-11-18 2015-04-28 Mitsui Sugar Co., Ltd. Method of using isomaltulose to suppress blood glucose level increase

Also Published As

Publication number Publication date
JPS6354691B2 (enExample) 1988-10-28

Similar Documents

Publication Publication Date Title
KR100474625B1 (ko) 말토덱스트린및아미노산을함유하는복막투석용액
KR0145289B1 (ko) 히스티딘 완충 복막 투석 용액
AU754537B2 (en) Novel pharmaceutical composition for use in emergency treatment and preparation method thereof
US5112865A (en) Pharmaceutical compositions containing a derivative of 3-hydroxybutanoic acid chosen from oligomers of this acid and esters of this acid or of these oligomers with 1,3-butanediol
CA1187801A (en) Dialysis solution containing glycerol
JP4638106B2 (ja) 医薬的使用のための溶液中における浸透圧剤としての、ｌ−カルニチンおよびそのアルカノイル誘導体の使用
DE69332106T3 (de) Lösung für die Peritonealdialyse
US6720011B1 (en) Injectable composition for cancer treatment
Worthley Hyperosmolar coma treated with intravenous sterile water: a study of three cases
DE60022759T2 (de) Erythropoietin formulierungen des mehrfachdosis-typs
Rottembourg et al. Clinical aspects of continuous ambulatory and continuous cyclic peritoneal dialysis in diabetic patients
JPS6251616A (ja) 糖質輸液剤
CN1244403A (zh) 一种参麦等渗注射液的制备方法
JPH02191212A (ja) ３―ヒドロキシ酪酸（β―ヒドロキシ酪酸）及びその塩からなる輸液製剤
RU2114617C1 (ru) Антидиабетическое средство на основе янтарной кислоты
JP3644024B2 (ja) 腹膜透析液
JP3572085B2 (ja) 栄養輸液剤
JP3643879B2 (ja) 電解質輸液組成物
JP3214116B2 (ja) 術中輸液製剤
KR20150120277A (ko) C형 바이러스 간염 치료제
Coulston et al. Comparison of parenterally administered calcium kinate gluconate with calcium gluconate and calcium chloride
Powell Jugular vein obstruction caused by turning of the head: CA Gooding and GK Stimac. Am J Roentgenol 142: 403–406,(February), 1984
Raker Blood-glucose concentrations during anaesthesia in children. Effects of Starvation and perioperative fluid therapy: K. Nilsson, LE Larsson, S. Andreasson, et al. Br J Anaesth 56: 375–378,(April), 1984
Whalen Human bites in children: P. Schweih and G. Fleisher. Pediatr Emerg Care 1: 51–53,(June), 1985
Dickson Accidental ingestion of sterilizing tablets by children: MZ Siodlak, MJ Glesson, and CL Wengraf. Br Med J 290: 1707–1708,(June), 1985